Altiratinib T2054
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
CAS nr:
1345847-93-9
Purity:
98%
Molecular Weight:
510,46
SMILES:
FC1=CC=C(NC(=O)C2(CC2)C(=O)NC2=CC(F)=C(OC3=CC(NC(=O)C4CC4)=NC=C3)C=C2F)C=C1
Formula:
C26H21F3N4O4
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors
Target:
FLT,FLT,VEGFR,VEGFR,Tie-2,Trk receptor,c-Met/HGFR
